Status:
COMPLETED
GOIZ ZAINDU Feasibility Multi Domain Trial to Prevent Dementia.
Lead Sponsor:
Fundacion CITA-alzheimer
Collaborating Sponsors:
Biogipuzkoa Health Research Institute
Conditions:
Cognitive Decline
Dementia Risk Factors
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
GOIZ ZAINDU ("caring early" in Basque) is a pilot study to adapt the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) methodology to the Basque population a...
Detailed Description
The GOIZ ZAINDU pilot trial is a one-year controlled, randomized, multidomain intervention trial, for prevention of cognitive decline, carried out in the municipality of Beasain in the Basque Country ...
Eligibility Criteria
Inclusion
- Participants were at least 60 years of age,
- had a CAIDE score ≥ 6 points and
- performed below than expected in at least one of two brief cognitive tests - Memory alteration test (T@M) and Fototest
- or scored two or higher in the AD8 informant's questionnaire of cognitive symptoms.
Exclusion
- Exclusion criteria included the presence of poorly controlled cardiovascular or respiratory disease,
- previous diagnosis of dementia, ongoing neurological disorders, unstable psychiatric disease, evidence of any other severe disease of any etiology,
- or any situation, in the investigator's opinion, that could compromise safe engagement in the intervention.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06163716
Start Date
April 1 2018
End Date
March 1 2020
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CITA-alzheimer
Donostia / San Sebastian, Gipuzkoa, Spain, 20009